Effect of ketamine dose on self-rated dissociation in patients with treatment refractory anxiety disorders
Journal of Psychopharmacology October 1, 2017 Cameron Castle, Andrew Gray, Shona Neehoff et al. 20 citations
Patients receiving ketamine for refractory depression and anxiety report dissociative symptoms in the first 60 min post-dose. The most commonly used instrument to assess this is the Clinician-Administered Dissociative States Scale (CADSS), developed based on the assessment of patients with dissociative symptoms. Its psychometric properties for ketamine-induced dissociation have not been...